Diabetic Retinopathy Diagnosis based on Convolutional Neural Network in the Russian Population: A Multicenter Prospective Study
- Authors: Gognieva D.1, Moshetova L.2, Sychev D.2, Budzinskaya M.3, Pavlov V.3, Yusef Y.3, Abdullaev M.1, Al-Dwa B.1, Bektimirova A.1, Kuznetsova N.1, Suvorov A.1, Chomakhidze P.1, Vorobyeva I.1, Durzhinskaya M.1, Kopylov P.1
-
Affiliations:
- World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
- Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
- Research Institute of Eye Diseases Named After M.M. Krasnov, Federal State Budgetary Institution, Moscow, Russia
- Issue: Vol 20, No 8 (2024)
- Section: Medicine
- URL: https://snv63.ru/1573-3998/article/view/643034
- DOI: https://doi.org/10.2174/0115733998268034231101091236
- ID: 643034
Cite item
Full Text
Abstract
Background::Diabetic retinopathy is the most common complication of diabetes mellitus and is one of the leading causes of vision impairment globally, which is also relevant for the Russian Federation.
Objective::To evaluate the diagnostic efficiency of a convolutional neural network trained for the detection of diabetic retinopathy and estimation of its severity in fundus images of the Russian population.
Methods::In this cross-sectional multicenter study, the training data set was obtained from an open source and relabeled by a group of independent retina specialists; the sample size was 60,000 eyes. The test sample was recruited prospectively, 1186 fundus photographs of 593 patients were collected. The reference standard was the result of independent grading of the diabetic retinopathy stage by ophthalmologists.
Results::Sensitivity and specificity were 95.0% (95% CI; 90.8-96.4) and 96.8% (95% CI; 95.5- 99.0), respectively; positive predictive value 98.8% (95% CI; 97.6-99.2); negative predictive value 87.1% (95% CI, 83.4-96.5); accuracy 95.9% (95% CI; 93.3-97.1); Kappa score 0.887 (95% CI; 0.839-0.946); F1score 0.909 (95% CI; 0.870-0.957); area under the ROC-curve 95.9% (95% CI; 93.3-97.1). There was no statistically significant difference in diagnostic accuracy between the group with isolated diabetic retinopathy and those with hypertensive retinopathy as a concomitant diagnosis.
Conclusion::The method for diagnosing DR presented in this article has shown its high accuracy, which is consistent with the existing world analogues, however, this method should prove its clinical efficiency in large multicenter multinational controlled randomized studies, in which the reference diagnostic method would be unified and less subjective than an ophthalmologist.
About the authors
Daria Gognieva
World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow StateMedical University (Sechenov University), Moscow, Russia
Author for correspondence.
Email: info@benthamscience.net
Larisa Moshetova
Federal State Budgetary Educational Institution of FurtherProfessional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of
Healthcare of the Russian Federation, Moscow, Russia
Email: info@benthamscience.net
Dmitry Sychev
Federal State Budgetary Educational Institution of FurtherProfessional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of
Healthcare of the Russian Federation, Moscow, Russia
Email: info@benthamscience.net
Maria Budzinskaya
Research Institute of Eye Diseases Named After M.M.Krasnov, Federal State Budgetary Institution, Moscow, Russia
Email: info@benthamscience.net
Vladislav Pavlov
Research Institute of Eye Diseases Named After M.M.Krasnov, Federal State Budgetary Institution, Moscow, Russia
Email: info@benthamscience.net
Yusef Yusef
Research Institute of Eye Diseases Named After M.M.Krasnov, Federal State Budgetary Institution, Moscow, Russia
Email: info@benthamscience.net
Magomed Abdullaev
World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow StateMedical University (Sechenov University), Moscow, Russia
Email: info@benthamscience.net
Baraah Al-Dwa
World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow StateMedical University (Sechenov University), Moscow, Russia
Email: info@benthamscience.net
Alina Bektimirova
World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow StateMedical University (Sechenov University), Moscow, Russia
Email: info@benthamscience.net
Natalia Kuznetsova
World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow StateMedical University (Sechenov University), Moscow, Russia
Email: info@benthamscience.net
Alexander Suvorov
World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow StateMedical University (Sechenov University), Moscow, Russia
Email: info@benthamscience.net
Petr Chomakhidze
World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow StateMedical University (Sechenov University), Moscow, Russia
Email: info@benthamscience.net
Irina Vorobyeva
World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow StateMedical University (Sechenov University), Moscow, Russia
Email: info@benthamscience.net
Madina Durzhinskaya
World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow StateMedical University (Sechenov University), Moscow, Russia
Email: info@benthamscience.net
Philipp Kopylov
World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow StateMedical University (Sechenov University), Moscow, Russia
Email: info@benthamscience.net
Supplementary files
